Jesús Aguilar Castro

Dr. Jesús Aguilar Castro

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
LCLuis Cervantes
Luis Cervantes
JCJesús Aguilar Castro
Jesús Aguilar Castro
FBFidel Orlando Buendía-González
Fidel Orlando Buendía-González
OFOmar Fernandez-Rivera
Omar Fernandez-Rivera
ACArmando Cervantes-Sandoval
Armando Cervantes-Sandoval
MLMartha Legorreta-Herrera
Martha Legorreta-Herrera
Malaria is the most lethal parasitic disease in the world. Mortality and severity in symptoms are higher in men than women, suggesting that oestrogens, which are in higher concentration in females than in males, may regulate the immune response against malaria. Tamoxifen, a selective oestrogen receptor modulator used in breast cancer treatment due to its antagonistic effect on oestrogen receptors α and β, is also studied because of its potential therapeutic use for several parasitic diseases. However, most studies, including one in malaria, have not addressed the immunomodulatory role of tamoxifen. In this work, we evaluated the effect of tamoxifen on the immune response of CBA/Ca mice against Plasmodium berghei ANKA. This study showed for the first time that tamoxifen increased parasite load, aggravated symptoms by decreasing body temperature and body weight, and worsened anaemia. Additionally, tamoxifen significantly increased the splenic index and the percentages of CD4+ and NK+ cells on day eight post-infection. By contrast, tamoxifen decreased both CD8+ and B220+ populations in the spleen and decreased the serum levels of IL-2, IL-6, and IL-17. Our findings support the notion that tamoxifen is a potent immunomodulator in malaria-infected mice and suggest caution when administering it to malaria-infected women with breast cancer.

1 January 2020 in Immunobiology
Verified
Journal Article
Closed access
JCJesús Aguilar Castro
Jesús Aguilar Castro
LCLuis Cervantes
Luis Cervantes
FBFidel Orlando Buendía-González
Fidel Orlando Buendía-González
TNTeresita de Jesús Nolasco-Pérez
Teresita de Jesús Nolasco-Pérez
MLMonserrat Sofía López-Padilla
Monserrat Sofía López-Padilla
MLMartha Legorreta-Herrera
Martha Legorreta-Herrera

Verified
Journal Article
Open access
PDF file
TNTeresita de Jesús Nolasco-Pérez
Teresita de Jesús Nolasco-Pérez
VSVICTOR HUGO SALAZAR-CASTAÑON
VICTOR HUGO SALAZAR-CASTAÑON
LCLuis Cervantes
Luis Cervantes
FGFidel Orlando Buendía González
Fidel Orlando Buendía González
JCJesús Aguilar Castro
Jesús Aguilar Castro
MLMartha Legorreta-Herrera
Martha Legorreta-Herrera
Malaria, the deadliest parasitic disease in the world, is sexually dimorphic, inflammatory, and oxidative. Males experience more severe symptoms and mortality than females do; therefore, the roles of 17β-estradiol and testosterone in this phenomenon have been studied. Both hormones affect oxidative stress, the primary mechanism of Plasmodium elimination. Estradiol has antioxidant activity, but the role of testosterone is controversial. Testosterone increases oxidative stress by reducing superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) activities, which increase lipoperoxidation in the testis. However, the antioxidant properties of testosterone in prostate and nervous tissue have also been reported. The discrepancies are probably because when testosterone levels increase, the aromatase enzyme transforms testosterone into estrogens that possess antioxidant activity, which masks the results. Therefore, it is unknown whether testosterone is involved in the sexual dimorphism that occurs in oxidative stress in malaria. In this work, we administered testosterone and simultaneously inhibited aromatase with letrozole to evaluate the role of testosterone in the sexually dimorphic pattern of oxidative stress that occurs in the blood, spleen, and brain of male and female CBA/Ca mice infected with Plasmodium berghei ANKA (P. berghei ANKA). Testosterone triggers parasitemia in males, who also display more oxidative stress than females in the absence of infection, leading to sexually dimorphic patterns. Interestingly, increasing testosterone levels in infected mice reduced oxidative stress in males and increased oxidative stress in females, reversing or eliminating the dimorphic patterns observed. Oxidative stress varies in each tissue; the brain was the most protected, while the blood was the greatest damaged. Our findings highlight the role of testosterone as a regulator of oxidative stress in a tissue and sex-specific manner; therefore, understanding the role of testosterone in malaria may contribute to the development of sex-specific personalized antimalarial therapies.

Verified
Journal Article
Open access
PDF file
FGFidel Orlando Buendía González
Fidel Orlando Buendía González
LCLuis Cervantes
Luis Cervantes
JCJesús Aguilar Castro
Jesús Aguilar Castro
OFOmar Fernandez-Rivera
Omar Fernandez-Rivera
TNTeresita de Jesús Nolasco-Pérez
Teresita de Jesús Nolasco-Pérez
MLMartha Legorreta-Herrera
Martha Legorreta-Herrera
Malaria is the most lethal parasitic disease worldwide; the severity of symptoms and mortality are higher in men than in women, exhibiting an evident sexual dimorphism in the immune response; therefore, the contribution of 17β-estradiol and testosterone to this phenomenon has been studied. Both hormones differentially affect several aspects of innate and adaptive immunity. Dehydroepiandrosterone (DHEA) is the precursor of both hormones and is the sexual steroid in higher concentrations in humans, with immunomodulatory properties in different parasitic diseases; however, the involvement of DHEA in this sexual dimorphism has not been studied. In the case of malaria, the only information is that higher levels of DHEA are associated with reduced Plasmodium falciparum parasitemia. Therefore, this work aims to analyze the DHEA contribution to the sexual dimorphism of the immune response in malaria. We assessed the effect of modifying the concentration of DHEA on parasitemia, the number of immune cells in the spleen, cytokines, and antibody levels in plasma of CBA/Ca mice infected with Plasmodium berghei ANKA (P. berghei ANKA). DHEA differentially affected the immune response in males and females: it decreased IFN-γ, IL-2 and IL-4 concentrations only in females, whereas in gonadectomized males, it increased IgG2a and IgG3 antibodies. The results presented here show that DHEA modulates the immune response against Plasmodium differently in each sex, which helps to explain the sexual dimorphism present in malaria.

30 December 2023 in Casos y Revisiones de Salud
Verified
Journal Article
Closed access
JCJesús Aguilar Castro
Jesús Aguilar Castro

27 December 2024 in Casos y Revisiones de Salud
Verified
Journal Article
Closed access
MNMisael Isaac Narváez-Murillo
Misael Isaac Narváez-Murillo
JCJesús Aguilar Castro
Jesús Aguilar Castro
Antecedentes. Actualmente, no se dispone de un tratamiento que alivie todos los síntomas del cáncer, por lo que se utilizan aditivos o coadyuvantes junto el tratamiento para mejorar su eficacia. Una de las propuestas más recientes es el factor de transferencia (FT), aunque no se cuenta con suficiente evidencia de su efecto. Objetivo. Presentar una síntesis del conocimiento sobre el efecto del FT, como coadyuvante, sobre la sobrevida de pacientes con cáncer a través de una revisión sistemática. Método. Se llevó a cabo una búsqueda de artículos en las plataformaPubMed, Web of Science, Lilacs, Scopus, SciELO y TesiUNAM hasta el 24 de junio de 2022, para realizar una revisión sistemática acorde con los criterios PRISMA, considerando como variable de desenlace la sobrevida de pacientes con FT en comparación con controles. Se analizó el porcentaje de supervivencia con respecto al tiempo. Resultados. Se analizaron 4 estudios que cumplieron los criterios de elegibilidad, sumando una muestra total de n=194 participantes, quienes recibieron FT y n=228 fueron controles. Se encontró que el factor de transferencia no afecta significativamente la sobrevida, en comparación al control. Conclusión. Los resultados sugieren que el factor de transferencia no favorece la sobrevida de los pacientes con cáncer.